Abstract
Background
Limited knowledge exists on the virulence factors of Candida tropicalis and the mechanisms of azole resistance that lead to an intensified pathogenicity and treatment failure. We aimed to evaluate the virulence factors and molecular mechanisms of azole resistance among C. tropicalis isolated from patients with candidemia.
Materials and Methods
Several virulence factors, including extracellular enzymatic activities, cell surface hydrophobicity (CSH), and biofilm formation, were evaluated. Antifungal susceptibility pattern and expression level of ERG11, UPC2, MDR1, and CDR1 genes of eight (4 fluconazole resistance and 4 fluconazole susceptible) clinical C. tropicalis isolates were assessed. The correlation between the virulence factors and antifungal susceptibility patterns was analyzed.
Results
During a 4 year study, forty-five C. tropicalis isolates were recovered from candidemia patients. The isolates expressed different frequencies of virulence determinants as follows: coagulase 4 (8.9%), phospholipase 5 (11.1%), proteinase 31 (68.9%), esterase 43 (95.6%), hemolysin 44 (97.8%), biofilm formation 45 (100%) and CSH 45(100%). All the isolates were susceptible to amphotericin B and showed the highest resistance to voriconazole. There was a significant positive correlation between micafungin minimum inhibitory concentrations (MICs) and hemolysin production (rs = 0.316). However, we found a negative correlation between fluconazole MICs and esterase production (rs = −0.383). We observed the high expression of ERG11 and UPC2 genes in fluconazole-resistant C. tropicalis isolates.
Conclusion
C. tropicalis isolated from candidemia patients extensively displayed capacities for biofilm formation, hemolysis, esterase activity, and hydrophobicity. In addition, the overexpression of ERG11 and UPC2 genes was considered one of the possible mechanisms of azole resistance.
Similar content being viewed by others
References
Bassetti M, Merelli M, Ansaldi F, de Florentiis D, Sartor A, Scarparo C, Callegari A, Righi E. Clinical and therapeutic aspects of candidemia: a five year single centre study. PLoS ONE. 2015. https://doi.org/10.1371/journal.pone.0127534.
Canela HMS, Cardoso B, Vitali LH, Coelho HC, Martinez R, da Silva Ferreira MF. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. Mycoses. 2018. https://doi.org/10.1111/myc.12695.
Sasani E, Khodavaisy S, Rezaie S, Salehi M, Yadegari MH. The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia. Microbial Pathogenesis. 2021. https://doi.org/10.1016/j.micpath.2021.104889.
Santos ERd, Forno CFD, Hernandez MG, Kubiça TF, Venturini TP, Chassot F, Santurio JM, Alves SH. Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27–A3 and new M27–S4 approved breakpoints. Rev Inst Med Trop. 2014. https://doi.org/10.1590/S0036-46652014000600004.
Ahangarkani F, Shokohi T, Rezai MS, Ilkit M, Nesheli HM, Karami H, Tamaddoni A, Alizadeh-Navaei R, Khodavaisy S, Meis JF, Badali H. Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran. Mycoses. 2020. https://doi.org/10.1111/myc.13053.
Da Costa VG, Quesada RMB, Abe ATS, Furlaneto-Maia L, Furlaneto MC. Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey. Mycopathologia. 2014. https://doi.org/10.1007/s11046-014-9791-z.
Silva-Dias A, Miranda IM, Branco J, Monteiro-Soares M, Pina-Vaz C, Rodrigues AG. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. Front microbiol. 2015. https://doi.org/10.3389/fmicb.2015.00205.
Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, Eshwara VK, Xess I, Kindo AJ, Umabala Savio JP, Patel A, Ray U, Mohan S, Iyer R, Chander J, Arora A, Sardana R, Roy I, Appalaraju B, Sharma A, Shetty A, Khanna N, Marak R, Biswas S, Das S, Harish BN, Mendiratta JSD. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015. https://doi.org/10.1007/s00134-014-3603-2.
Vaezi A, Fakhim H, Khodavaisy S, Alizadeh A, Nazeri M, Soleimani A, Boekhout T, Badali H. Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis. J Mycol Med. 2017. https://doi.org/10.1016/j.mycmed.2017.02.007.
Negri M, Silva S, Henriques M, Oliveira R. Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis. 2012. https://doi.org/10.1007/s10096-011-1455-z.
Chin VK, Foong KJ, Maha A, Rusliza B, Norhafizah M, Ng KP, Chong PP. Candida albicans isolates from a Malaysian hospital exhibit more potent phospholipase and haemolysin activities than non-albicans Candida isolates. Trop. Biomed. 2013.
Mattei AS, Alves SH, Severo CB, da Silva GL, de Mattos OF, Severo LC. Determination of germ tube, phospholipase, and proteinase production by bloodstream isolates of Candida albicans. Rev Soc Bras Med Trop. 2013. https://doi.org/10.1590/0037-8682-0045-2013.
Neji S, Hadrich I, Trabelsi H, Abbes S, Cheikhrouhou F, Sellami H, Makni F, Ayadi A. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens. J Biomed Sci. 2017. https://doi.org/10.1186/s12929-017-0376-2.
Fan X, Xiao M, Liao K, Kudinha T, Wang H, Zhang L, Hou X, Kong F, Xu Y. Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption. Front microbial. 2017. https://doi.org/10.3389/fmicb.2017.00464.
Fan X, Xiao M, Zhang D, Huang J-J, Wang H, Hou X, Zhang L, Kong F, Chen SC-A, Tong Z-H, Xu Y-C. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Clin Microbiol Infect. 2019. https://doi.org/10.1016/j.cmi.2018.11.007.
Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, Peng Y. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013. https://doi.org/10.1093/jac/dks481.
Jiang C, Ni Q, Dong D, Zhang L, Li Z, Tian Y, Peng Y. The role of UPC2 gene in azole-resistant Candida tropicalis. Mycopathologia. 2016. https://doi.org/10.1007/s11046-016-0050-3.
Arastehfar A, Daneshnia F, Hafez A, Khodavaisy S, Najafzadeh M-J, Charsizadeh A, Zarrinfar H, Salehi M, Shahrabadi ZZ, Sasani E, Zomorodian K, Pan W, Hagen F, Ilkit M, Kostrzewa M, Boekhout T. Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates. Med Mycol J. 2020. https://doi.org/10.1093/mmy/myz124.
Arastehfar A, Daneshnia F, Kord M, Roudbary M, Zarrinfar H, Fang W, Hashemi SJ, Najafzadeh MJ, Khodavaisy S, Pan W, Liao W, Badali H, Rezaie S, Zomorodian K, Hagen F, Boekhout T. Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA sequencing for a wide range of clinically isolated yeast species: Improved identification by combining 21-Plex PCR and API 20C AUX as an alternative strategy for developing countries. Front Cell Infect Microbiol. 2019. https://doi.org/10.3389/fcimb.2019.00021.
Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun. 1994. https://doi.org/10.1128/iai.62.11.5154-5156.1994.
Ells R, Kilian W, Hugo A, Albertyn J, Kock JLF, Pohl CH. Virulence of South African Candida albicans strains isolated from different clinical samples. Med Mycol J. 2014. https://doi.org/10.1093/mmy/myt013.
Staib F. Serum-proteins as nitrogen source for yeastlike fungi. J Med Vet Mycol. 1966;4:187–93.
Polak A. Virulence of Candida albicans mutants: Virulenz von Candida albicans-Mutanten. Mycoses. 1992. https://doi.org/10.1111/j.1439-0507.1992.tb00813.x.
Slifkin M. Tween 80 opacity test responses of variousCandida species. J Clin Microbiol. 2000. https://doi.org/10.1128/JCM.38.12.4626-4628.2000.
Shukla SK, Rao TS. An improved crystal violet assay for biofilm quantification in 96-well microtiter plate. Biorxiv. 2017. https://doi.org/10.1101/100214.
Yigit N, Aktas E, Dagistan S, Ayyildiz A. Investigating biofilm production, coagulase and hemolytic activity in Candida species isolated from denture stomatitis patients. Eurasian J Med. 2011. https://doi.org/10.5152/eajm.2011.06.
Wayne PA (2008a) CLSI, Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3 and Supplement S
Wayne P (2012) Clinical and Laboratory Standards Institute. Reference Method for Broth Dilutionn Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement M27-S4
Wayne PA (2018) CLSI, Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 2nd ed., CLSI Supplement M59. 2nd ed: Clinical and Laboratory Standards Institute
Kord M, Salehi M, Khodavaisy S, Hashemi SJ, Ghazvini RD, Rezaei S, Maleki A, Elmimoghaddam A, Alijani N, Abdollahi A, Doomanlou M, Ahmadikia K, Rashidi N, Pan W, Boekhout T, Arastehfar A. Epidemiology of yeast species causing bloodstream infection in Tehran, Iran (2015–2017); superiority of 21-plex PCR over the Vitek 2 system for yeast identification. J. Med. Microbiol. 2020. https://doi.org/10.1099/jmm.0.001189.
Sacristán B, Blanco MT, Galán-Ladero MA, Blanco J, Pérez-Giraldo C, Gómez-García AC. Aspartyl proteinase, phospholipase, hemolytic activities and biofilm production of Candida albicans isolated from bronchial aspirates of ICU patients. Med Mycol J. 2011. https://doi.org/10.3109/13693786.2010.482947.
Sachin C, Ruchi K, Santosh S. In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens. Int J Med Biomed Res. 2012. https://doi.org/10.14194/ijmbr.1211.
Atalay MA, Koc AN, Demir G, Sav H. Investigation of possible virulence factors in Candida strains isolated from blood cultures. Niger J Clin Pract. 2015. https://doi.org/10.4103/1119-3077.146979.
Deorukhkar SC, Saini S, Mathew S. Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile. Int J Microbiol. 2014. https://doi.org/10.1155/2014/456878.
Tellapragada C, Eshwara VK, Johar R, Shaw T, Malik N, Bhat PV, Kamath A, Mukhopadhyay C. Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis. J Pathog. 2014. https://doi.org/10.1155/2014/142864.
Sriphannam C, Nuanmuang N, Saengsawang K, Amornthipayawong D, Kummasook A. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures. J Mycol Med. 2019. https://doi.org/10.1016/j.mycmed.2019.08.001.
Linares CEB, de Loreto ES, Silveira CP, Pozzatti P, Scheid LA, Santurio JM, Alves SH. Enzymatic and hemolytic activities of Candida dubliniensis strains. Rev Inst Med Trop Sao Paulo. 2007. https://doi.org/10.1590/S0036-46652007000400001.
França EJG, Furlaneto-Maia L, Quesada RMB, Favero D, Oliveira MT, Furlaneto MC. Haemolytic and proteinase activities in clinical isolates of Candida parapsilosis and Candida tropicalis with reference to the isolation anatomic site. Mycoses. 2011. https://doi.org/10.1111/j.1439-0507.2009.01825.x.
Mushi MF, Bader O, Bii C, Gro U, Mshana SE. Virulence and susceptibility patterns of clinical Candida spp. isolates from a tertiary hospital Tanzania. Med Mycol J. 2019. https://doi.org/10.1093/mmy/myy107.
Rodrigues AG, Pina-Vaz C, Costa-de-Oliveira S, Tavares C. Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol. 2003. https://doi.org/10.1128/JCM.41.12.5792-5793.2003.
Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, de Gaetano DK, Sorda ML, Spanu T, Fadda G, Cauda R, Sanguinetti M. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. Clin Microbiol Infect. 2007. https://doi.org/10.1128/JCM.00131-07.
Negri M, Silva S, Capoci IRG, Azeredo J, Henriques M. Candida tropicalis biofilms: biomass, metabolic activity and secreted aspartyl proteinase production. Mycopathologia. 2016. https://doi.org/10.1007/s11046-015-9964-4.
Negri E, Martins M, Henriques M, Svidzinski TLE, Oliveira JAR. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia. 2010. https://doi.org/10.1007/s11046-009-9246-0.
Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002. https://doi.org/10.1093/jac/dkf049.
Wu P-F, Liu W-L, Hsieh M-H, Hii I-M, Lee Y-L, Lin Y-T, Ho M-W, Liu CY-H, Wang F-D. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients: non-albicans candidemia in cancer patients. Emerg Microbes Infect. 2017. https://doi.org/10.1038/emi.2017.74.
Khan Z, Ahmad S, Al-Sweih N, Mokaddas E, AlBanwan K, Alfouzan W, Al-Obaid I, Al-Obaid K, Asadzadeh M, Jeragh A, Joseph L, Varghese S, Vayalil S, Al-Musallam O. Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait. PLoS ONE. 2019. https://doi.org/10.1371/journal.pone.0216250.
Vandeputte P, Larcher G, Bergès T, Renier G, Chabasse D, Bouchara J-P. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother. 2005. https://doi.org/10.1128/AAC.49.11.4608-4615.2005.
Choi MJ, Won EJ, Shin JH, Kim SH, Lee W-G, Kim M-N, Lee K, Shin MG, Suh SP, Ryang DW, Im YJ. Resistance mechanisms and clinical features of fluconazole-nonsusceptible Candida tropicalis isolates compared with fluconazole-less-susceptible isolates. Antimicrob Agents Chemother. 2016. https://doi.org/10.1128/AAC.02652-15.
Barchiesi F, Calabrese D, Sanglard D, Di Francesco LF, Caselli F, Giannini D, Giacometti A, Gavaudan S, Scalise G. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother. 2000. https://doi.org/10.1128/AAC.44.6.1578-1584.2000.
Acknowledgements
This study has been supported by the Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran (Med80531). This study has been funded and supported by Tehran University of Medical Sciences (TUMS); Grant no. 1400-1-99-53171.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Handling Editor: Nilce M. Martinez-Rossi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sasani, E., Yadegari, M.H., Khodavaisy, S. et al. Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia. Mycopathologia 186, 847–856 (2021). https://doi.org/10.1007/s11046-021-00580-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-021-00580-y